1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Breast Cancer 1.2.3 Blood Cancer 1.2.4 Lung Cancer 1.2.5 Colorectal Cancer 1.2.6 Ovarian Cancer 1.2.7 Others 1.3 Market by Application 1.3.1 Global Cancer Diagnostics Service Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Diagnostic Laboratories 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Diagnostics Service Market Perspective (2017-2028) 2.2 Cancer Diagnostics Service Growth Trends by Region 2.2.1 Cancer Diagnostics Service Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2017-2022) 2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028) 2.3 Cancer Diagnostics Service Market Dynamics 2.3.1 Cancer Diagnostics Service Industry Trends 2.3.2 Cancer Diagnostics Service Market Drivers 2.3.3 Cancer Diagnostics Service Market Challenges 2.3.4 Cancer Diagnostics Service Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Diagnostics Service Players by Revenue 3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2017-2022) 3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2017-2022) 3.2 Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cancer Diagnostics Service Revenue 3.4 Global Cancer Diagnostics Service Market Concentration Ratio 3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2021 3.5 Cancer Diagnostics Service Key Players Head office and Area Served 3.6 Key Players Cancer Diagnostics Service Product Solution and Service 3.7 Date of Enter into Cancer Diagnostics Service Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Diagnostics Service Breakdown Data by Type 4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2017-2022) 4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028) 5 Cancer Diagnostics Service Breakdown Data by Application 5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2017-2022) 5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cancer Diagnostics Service Market Size (2017-2028) 6.2 North America Cancer Diagnostics Service Market Size by Country (2017-2022) 6.3 North America Cancer Diagnostics Service Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Cancer Diagnostics Service Market Size (2017-2028) 7.2 Europe Cancer Diagnostics Service Market Size by Country (2017-2022) 7.3 Europe Cancer Diagnostics Service Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2017-2028) 8.2 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2017-2022) 8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Cancer Diagnostics Service Market Size (2017-2028) 9.2 Latin America Cancer Diagnostics Service Market Size by Country (2017-2022) 9.3 Latin America Cancer Diagnostics Service Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2017-2028) 10.2 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022) 10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Illumina 11.1.1 Illumina Company Detail 11.1.2 Illumina Business Overview 11.1.3 Illumina Cancer Diagnostics Service Introduction 11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2017-2022) 11.1.5 Illumina Recent Development 11.2 BGI Genomics Co.,Ltd. 11.2.1 BGI Genomics Co.,Ltd. Company Detail 11.2.2 BGI Genomics Co.,Ltd. Business Overview 11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction 11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022) 11.2.5 BGI Genomics Co.,Ltd. Recent Development 11.3 Agilent Technologies 11.3.1 Agilent Technologies Company Detail 11.3.2 Agilent Technologies Business Overview 11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction 11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022) 11.3.5 Agilent Technologies Recent Development 11.4 Macrogen 11.4.1 Macrogen Company Detail 11.4.2 Macrogen Business Overview 11.4.3 Macrogen Cancer Diagnostics Service Introduction 11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022) 11.4.5 Macrogen Recent Development 11.5 Pacific Biosciences 11.5.1 Pacific Biosciences Company Detail 11.5.2 Pacific Biosciences Business Overview 11.5.3 Pacific Biosciences Cancer Diagnostics Service Introduction 11.5.4 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022) 11.5.5 Pacific Biosciences Recent Development 11.6 Abbott 11.6.1 Abbott Company Detail 11.6.2 Abbott Business Overview 11.6.3 Abbott Cancer Diagnostics Service Introduction 11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2017-2022) 11.6.5 Abbott Recent Development 11.7 QIAGEN 11.7.1 QIAGEN Company Detail 11.7.2 QIAGEN Business Overview 11.7.3 QIAGEN Cancer Diagnostics Service Introduction 11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022) 11.7.5 QIAGEN Recent Development 11.8 Siemens Healthcare GmbH 11.8.1 Siemens Healthcare GmbH Company Detail 11.8.2 Siemens Healthcare GmbH Business Overview 11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction 11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022) 11.8.5 Siemens Healthcare GmbH Recent Development 11.9 Thermo Fisher Scientific, Inc. 11.9.1 Thermo Fisher Scientific, Inc. Company Detail 11.9.2 Thermo Fisher Scientific, Inc. Business Overview 11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction 11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022) 11.9.5 Thermo Fisher Scientific, Inc. Recent Development 11.10 Applied DNA Sciences 11.10.1 Applied DNA Sciences Company Detail 11.10.2 Applied DNA Sciences Business Overview 11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction 11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022) 11.10.5 Applied DNA Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Breast Cancer Table 3. Key Players of Blood Cancer Table 4. Key Players of Lung Cancer Table 5. Key Players of Colorectal Cancer Table 6. Key Players of Ovarian Cancer Table 7. Key Players of Others Table 8. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Cancer Diagnostics Service Market Share by Region (2017-2022) Table 12. Global Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Cancer Diagnostics Service Market Share by Region (2023-2028) Table 14. Cancer Diagnostics Service Market Trends Table 15. Cancer Diagnostics Service Market Drivers Table 16. Cancer Diagnostics Service Market Challenges Table 17. Cancer Diagnostics Service Market Restraints Table 18. Global Cancer Diagnostics Service Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Cancer Diagnostics Service Market Share by Players (2017-2022) Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021) Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Diagnostics Service Product Solution and Service Table 25. Date of Enter into Cancer Diagnostics Service Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Diagnostics Service Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Cancer Diagnostics Service Revenue Market Share by Type (2017-2022) Table 29. Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Cancer Diagnostics Service Revenue Market Share by Type (2023-2028) Table 31. Global Cancer Diagnostics Service Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Cancer Diagnostics Service Revenue Market Share by Application (2017-2022) Table 33. Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Cancer Diagnostics Service Revenue Market Share by Application (2023-2028) Table 35. North America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million) Table 45. Illumina Company Detail Table 46. Illumina Business Overview Table 47. Illumina Cancer Diagnostics Service Product Table 48. Illumina Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 49. Illumina Recent Development Table 50. BGI Genomics Co.,Ltd. Company Detail Table 51. BGI Genomics Co.,Ltd. Business Overview Table 52. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Table 53. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 54. BGI Genomics Co.,Ltd. Recent Development Table 55. Agilent Technologies Company Detail Table 56. Agilent Technologies Business Overview Table 57. Agilent Technologies Cancer Diagnostics Service Product Table 58. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 59. Agilent Technologies Recent Development Table 60. Macrogen Company Detail Table 61. Macrogen Business Overview Table 62. Macrogen Cancer Diagnostics Service Product Table 63. Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 64. Macrogen Recent Development Table 65. Pacific Biosciences Company Detail Table 66. Pacific Biosciences Business Overview Table 67. Pacific Biosciences Cancer Diagnostics Service Product Table 68. Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 69. Pacific Biosciences Recent Development Table 70. Abbott Company Detail Table 71. Abbott Business Overview Table 72. Abbott Cancer Diagnostics Service Product Table 73. Abbott Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 74. Abbott Recent Development Table 75. QIAGEN Company Detail Table 76. QIAGEN Business Overview Table 77. QIAGEN Cancer Diagnostics Service Product Table 78. QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 79. QIAGEN Recent Development Table 80. Siemens Healthcare GmbH Company Detail Table 81. Siemens Healthcare GmbH Business Overview Table 82. Siemens Healthcare GmbH Cancer Diagnostics Service Product Table 83. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 84. Siemens Healthcare GmbH Recent Development Table 85. Thermo Fisher Scientific, Inc. Company Detail Table 86. Thermo Fisher Scientific, Inc. Business Overview Table 87. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Table 88. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 89. Thermo Fisher Scientific, Inc. Recent Development Table 90. Applied DNA Sciences Company Detail Table 91. Applied DNA Sciences Business Overview Table 92. Applied DNA Sciences Cancer Diagnostics Service Product Table 93. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million) Table 94. Applied DNA Sciences Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Diagnostics Service Market Share by Type: 2021 VS 2028 Figure 2. Breast Cancer Features Figure 3. Blood Cancer Features Figure 4. Lung Cancer Features Figure 5. Colorectal Cancer Features Figure 6. Ovarian Cancer Features Figure 7. Others Features Figure 8. Global Cancer Diagnostics Service Market Share by Application in 2021 & 2028 Figure 9. Hospitals Case Studies Figure 10. Ambulatory Surgical Centers Case Studies Figure 11. Diagnostic Laboratories Case Studies Figure 12. Others Case Studies Figure 13. Cancer Diagnostics Service Report Years Considered Figure 14. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global Cancer Diagnostics Service Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Cancer Diagnostics Service Market Share by Region: 2021 VS 2028 Figure 17. Global Cancer Diagnostics Service Market Share by Players in 2021 Figure 18. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2021 Figure 20. North America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. North America Cancer Diagnostics Service Market Share by Country (2017-2028) Figure 22. United States Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Cancer Diagnostics Service Market Share by Country (2017-2028) Figure 26. Germany Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2017-2028) Figure 34. China Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Latin America Cancer Diagnostics Service Market Share by Country (2017-2028) Figure 42. Mexico Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Brazil Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2017-2028) Figure 46. Turkey Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 49. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 50. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 51. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 52. Pacific Biosciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 53. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 54. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 55. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 57. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Illumina BGI Genomics Co.,Ltd. Agilent Technologies Macrogen Pacific Biosciences Abbott QIAGEN Siemens Healthcare GmbH Thermo Fisher Scientific, Inc. Applied DNA Sciences